700161Business Plan for Gelexir LtdClosedGRD Proof of MarketInnovate UKThe purpose of the project is for the development of a Business Plan and Investment memorandum for Gelexir Ltd. This will include market assessment and competitive analysis, business strategy, regulatory approval plan, IP review as well as product development and testing plan. The Plan will be used for raising sufficient funds from institutional and private investors. These funds will be used for the implementation of; the clinical trials program, regulatory approval plan and necessary working capital taking the company to a commercial launch stage. The market is huge as Chronic lower back pain (CLBP) affects 55m people in the Western World and costs society many billions of £. The scientific founders are Professor Anthony Freemont, and Professor Brian Saunders at the University of Manchester.